IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Influence of Pomegranate Juice Consumption on the Level of Antioxidants in Breast Milk
The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified February 2013 by Hillel Yaffe Medical Center.
Recruitment status was: Not yet recruiting
Recruitment status was: Not yet recruiting
Sponsor:
Hillel Yaffe Medical Center
Information provided by (Responsible Party):
Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier:
NCT01800110
First received: February 19, 2013
Last updated: February 25, 2013
Last verified: February 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Many medicinal effects of Pomegranate juices are already known. Mainly known for its anti-viral, anti-bacterial and anti-oxide tendency of pomegranate juice.
Many studies which have demonstrated antioxidant activity of pomegranate juice in the blood and blood cells were published.
In addition, published studies have demonstrated the anti-oxidant activity which inhibit the development of atherosclerosis and stroke, even in patients with diabetes, and its effect of decreasing systolic blood pressure in patients with systemic hypertension.
The purpose of the work is to examine the effect of drinking pomegranate juice on the level of anti-oxidants in human breast milk.
| Condition | Intervention |
|---|---|
| Breast Milk | Dietary Supplement: pomegranate juice |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: None (Open Label) Primary Purpose: Basic Science |
| Official Title: | Influence of Pomegranate Juice Consumption on the Level of Antioxidants in Breast Milk |
Resource links provided by NLM:
Further study details as provided by Hillel Yaffe Medical Center:
Primary Outcome Measures:
- anti oxidant level in human breast milk [ Time Frame: at least one year ]
| Estimated Enrollment: | 40 |
| Study Start Date: | April 2013 |
| Estimated Primary Completion Date: | April 2015 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: 2
label I- 200 cc pomegranate juice once daily for 6 weeks post partum. label II- control group, no placebo is givening.
|
Dietary Supplement: pomegranate juice |
Detailed Description:
the effect of pomegranate juice consumption on breast milk anti oxidants level.
Eligibility| Ages Eligible for Study: | 16 Years to 45 Years (Child, Adult) |
| Sexes Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- lactating woman
Exclusion Criteria:
- pomegranate allergy
- diabetes mellitus
- use of other Dietary Supplement
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
No Contacts or Locations Provided
No Contacts or Locations Provided
More Information
| Responsible Party: | Hillel Yaffe Medical Center |
| ClinicalTrials.gov Identifier: | NCT01800110 History of Changes |
| Other Study ID Numbers: |
0013-13 |
| Study First Received: | February 19, 2013 |
| Last Updated: | February 25, 2013 |
Additional relevant MeSH terms:
|
Antioxidants Molecular Mechanisms of Pharmacological Action Protective Agents Physiological Effects of Drugs |
ClinicalTrials.gov processed this record on September 21, 2017